SCHEMBL7521871

SCHEMBL7521871

CC(C)(C)OC(=O)NC1CCN(c2ccc(Cl)c(C(=O)O)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SUV39H2 Q9H5I1 8/20 0.51
CKS1B P61024 1/20 0.48
SKP1 P63208 1/20 0.48
SKP2 Q13309 1/20 0.48
DRD2 P14416 3/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
DRD3 P35462 1/20 0.46
KCNA3 P22001 1/20 0.44
USP14 P54578 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPY5R Q15761 1/20 0.42
CTSB P07858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522232 0.94 SUV39H2 (0.53) SUV39H2CKS1BSKP1SKP2DRD2
SCHEMBL27655935 0.89 SUV39H2 (0.54) SUV39H2CKS1BSKP1SKP2DRD2
SCHEMBL21397261 0.85 SUV39H2 (0.51) SUV39H2CKS1BSKP1SKP2DRD2
SCHEMBL3108407 0.82 CNR1 (0.55) SUV39H2CKS1BSKP1SKP2DRD2
SCHEMBL25453973 0.81 SUV39H2 (0.50) SUV39H2CKS1BSKP1SKP2DRD2
SCHEMBL383106 0.81 USP2 (0.56) SUV39H2CKS1BSKP1SKP2DRD2
SCHEMBL28489283 0.81 AR (0.52) SUV39H2DRD2CNR1CNR2DRD3
SCHEMBL25703973 0.80 SUV39H2 (0.54) SUV39H2
SCHEMBL25285177 0.80 SUV39H2 (0.54) SUV39H2
SCHEMBL2271966 0.80 SUV39H2 (0.52) SUV39H2CKS1BSKP1SKP2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492355-B1 Adamantane derivatives ASTRAZENECA AB (SE) 2002-12-10 US disclosed
EP-1171432-A1 ADAMANTANE DERIVATIVES AstraZeneca AB (SE) 2002-01-16 EP disclosed
WO-2000061569-A1 ADAMANTANE DERIVATIVES ASTRAZENECA AB (SE) 2000-10-19 WO disclosed